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a b s t r a c t
Persistence is the most characteristic attribute of long-term memory (LTM). For memory persistence, a
second late event of consolidation, that occurs around 12 h after the acquisition, is necessary. Although
the N-methyl-D-aspartate (NMDA) receptor has been involved in the persistence of memory, whether
endogenous modulators of the NMDA receptor actually modulate memory persistence is unknown. In
the current study we investigated whether spermidine and arcaine, respectively agonist and antagonist
of polyamine binding site at NMDA receptor, alter the persistence of the memory of contextual fear
conditioning task in rats. While 12 h post-training administration of spermidine (10 and 30 mg/kg, i.p.)
facilitated, arcaine (10 mg/kg, i.p.) impaired the memory of fear assessed 2 and 7 days after training.
Arcaine (0.1 mg/kg) prevented the facilitatory effect of spermidine (10 mg/kg, i.p.), and spermidine
(1 mg/kg), prevented the memory impairment induced by arcaine (10 mg/kg, i.p.) when tested 2 and
7 days after training. These results suggest that endogenous polyamines improve the persistence of fear
memory.
& 2014 Elsevier B.V. All rights reserved.
1. Introduction
Current evidence suggests that memories are initially fragile,
but become more stable with time (McGaugh., 1966, 2000). Such
an observation has led to the concept of memory consolidation,
which refers to the stabilization of memory over time by neural
processes activated by recently learned information (Roesler and
McGaugh, 2010). Memories that last for several hours, days and
weeks are termed long-term memories (LTM).
Depending on the strength and/or saliency of the information
to be remembered, consolidated LTMs can persist for just 24–48 h,
or for many days or weeks (Countryman and Gold, 2007; Wang
et al., 2004). Persistence of LTM depends on a late consolidation
process, which occurs around 12 h after acquisition. The synthesis
of selected proteins, such as brain-derived neurotrophic factor
(BDNF), Homer 1a, Akt, CamKII, and ERK2 in the hippocampus
(Bekinschtein et al., 2007, 2010) increases during this phase.
Pharmacological manipulations that increase mitogen activated
kinases (MAPKs) and extracellular signal-regulated kinase (ERK)
phosphorylation, as well as synthesis of the transcription factors
Zif268 and c-Fos also facilitate memory persistence (Bekinschtein
et al., 2007, 2008, 2010). Recent studies have unveiled some of the
neurotransmitters and neuromodulators involved in this late
consolidation process (Medina et al., 2008). Accordingly, the
activity of muscarinic and nicotinic receptors at the CA1 region
12 h post-training is needed for memory persistence (Parﬁtt et al.,
2012), as well as the activation of dopamine and N-methyl-D-
aspartate (NMDA) receptors, and of cAMP-dependent protein
kinase (PKA) (Rossato et al., 2009). On the other hand, systemic
corticosterone or stress exposure during this time window impairs
memory persistence (Yang et al., 2013).
Polyamines are biologically active polycations that activate
NMDA receptor containing the GluN2B subunit by binding at a
dimer interface between GluN1 and GluN2B N-terminal domains
(Mony et al., 2011).
Accumulating evidence suggests that polyamines modulate
learning and memory (Kishi et al., 1998a, 1998b; Rubin et al.,
2000, 2001, 2004). Accordingly, systemic (Berlese et al., 2005;
Camera et al., 2007; Gomes et al., 2010; Guerra et al., 2006; Rubin
et al., 2000), and intra-amygdalar (Rubin et al., 2004) spermidine
improves the performance of rats in the inhibitory avoidance, fear
conditioning and social recognition tasks (Camera et al., 2007;
Mikolajczak et al., 2002) and facilitates the extinction (Gomes
et al., 2010) and the reconsolidation of the memory of fear (Ribeiro
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et al., 2013). Moreover, the administration of the polyamine
antagonist arcaine impairs the memory of inhibitory avoidance
(Ceretta et al., 2008; Rubin et al., 2001) and fear conditioning tasks
(Camera et al., 2007; Rubin et al., 2004), suggesting that endo-
genous polyamines may physiologically modulate memory
processing.
Despite the growing evidence suggesting a role for polyamines
in learning and memory processes, no study has addressed
whether polyamines modulate late consolidation processes.
Therefore, in the current study we investigated whether spermi-
dine and arcaine alter the persistence of the memory of fear
in rats.
2. Materials and methods
2.1. Animals
A total of 190 experimentally naive male Wistar rats (200–
280 g), from the animal house of the Federal University of Santa
Maria were used. The animals were housed four to a cage and
maintained on a 12 h light/dark cycle (lights on at 7:00 A.M.) at a
temperature of 21 1C with water and standard laboratory chow
(Guabi, Santa Maria, Rio Grande do Sul, Brazil) ad libitum. All
experimental procedures were conducted in accordance with the
policies on the use of animals and humans in neuroscience
research, revised and approved by the Society for Neuroscience
Research in January 1995 and with the institutional and national
regulations for animal research (process 068/2011).
2.2. Drugs
Animals were injected with saline (0.9% NaCl), 1,4-diguanidi-
nobutane sulfate (arcaine; Pfaltz& Bauer, Waterbury, CT, USA), or
N-(3-aminopropyl)-1.4-butanediamine trihydrochloride (spermi-
dine; Sigma, St. Louis, MO). All drug solutions were prepared daily
in saline and injections were performed intraperitoneally (i.p.) in a
1 ml/kg injection volume. Doses were selected based on previous
studies (Camera et al., 2007) and pilot experiments.
2.3. Apparatus
Contextual fear training and testing took place in an identical
observation chamber (302525 cm3), located in a well-lit
room. The front and ceiling walls of the chamber were made of
clear acrylic plastic, whereas the lateral and rear walls were made
of opaque plastic. The ﬂoor of the chamber consisted of 32
stainless steel rods (3 mm diameter), spaced 1 cm apart and wired
to a shock generator. The cage was cleaned with 30% ethyl alcohol
before and after each rat occupied it.
2.4. Contextual fear conditioning
Each animal was subjected to a single fear-conditioning train-
ing session, as described by Rubin et al. (2004), with some
modiﬁcations. In brief, the rat was placed in the conditioning
chamber (conditioned stimulus, CS) and habituated to the appa-
ratus for 3 min. Immediately after habituation, three 1 s, 0.4 mA
footshocks (unconditioned stimulus, US) were delivered. The
shocks were 40 s apart. After the last CS/US pairing, rats were
allowed to stay in the chamber for additional 60 s before returning
to their home cages.
Two or seven days after training, each rat was placed back in
the conditioning chamber and an 8 min test session was per-
formed. During this time, no shock was given, and every 4 s an
instantaneous observation of the rat was made to assess whether
it was in freezing, or not. Behavior was judged as freezing if there
was an absence of any visible movement, except for that required
for breathing. The percentage of samples scored as freezing during
this 8 min was taken as a contextual fear conditioning measure.
2.5. Statistical analyses
Data were analyzed by one- or two-way analysis of variance
(ANOVA) depending on the experimental design. Post hoc analyses
were carried out by the Student–Newman–Keuls test, when
indicated. A Po0.05 was considered signiﬁcant.
2.6. Experimental groups
2.6.1. Experiment 1
This experiment was designed to investigate the effect of
spermidine on the persistence of contextual fear memory. Animals
were trained in the fear conditioning apparatus, as described above.
Twelve hours post-training the animals received an intraperitoneal
injection of vehicle (saline) or spermidine (0.1–30 mg/kg) and, two
or seven days after training, were tested in the fear conditioning
apparatus, as described above.
2.6.2. Experiment 2
This experiment was designed to investigate the effect of
arcaine on the persistence of contextual fear memory. Animals
were trained in the fear conditioning apparatus, as described
above. Twelve hours post-training the animals received an intra-
peritoneal injection of vehicle (saline) or arcaine (0.1–10 mg/kg)
and, two or seven days after training, were tested in the fear
conditioning apparatus as described above.
2.6.3. Experiment 3
This experiment was designed to investigate the involvement
of polyamine-binding sites at the NMDA receptor in the facilitatory
effect of spermidine on the persistence of contextual fear memory.
The animals were trained in the fear conditioning apparatus and
11:30 h post-training the animals received an intraperitoneal
injection of vehicle (saline) or of the polyaminergic antagonist
arcaine (at doses that have no effect per se on memory, 0.1 mg/kg i.
p., as determined by the dose-effect curve shown in Fig. 2). Twelve
hours after training the animals received an intraperitoneal injec-
tion of vehicle (saline) or spermidine (10 mg/kg), in different
ﬂanks. Two or seven days after training, the animals were tested
in the fear conditioning apparatus and their freezing responses
were scored, as described above.
2.6.4. Experiment 4
In order to conﬁrm the involvement of polyamine-binding sites
at the NMDA receptor in the effect of polyamines, we investigated
whether spermidine prevents the deleterious effect of arcaine on
the persistence of contextual fear memory. The animals were
trained in the fear conditioning apparatus and, 11:30 h post-
training, the animals received an intraperitoneal injection of
vehicle (saline) or the polyaminergic agonist, spermidine (at doses
that have no effect per se on memory, 1 mg/kg i.p., determined by
the dose-effect curve shown in Fig. 1). Twelve hours after training,
the animals received an intraperitoneal injection of vehicle (saline)
or arcaine (10 mg/kg), in different ﬂanks. Two or seven days after
training, the animals were tested in the fear conditioning appara-
tus and their freezing responses were scored, as described above.
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3. Results
Fig. 1A and B shows the effect of the administration of
spermidine (0.1–30 mg/kg, i.p., 12 h post-training) on the memory
of fear assessed 2 or 7 days after training, respectively. Statistical
analysis (one-way ANOVA) revealed that spermidine, at the doses
of 3, 10 and 30 mg/kg, increased the freezing scores of animals
tested at 2 days [F6,28¼34.48, Po0.05, Fig. 1A] and the doses of 10
and 30 mg/kg, increased the freezing scores of animals tested at
7 days after training [F6,28¼4.907, Po0.05, Fig. 1B].
Fig. 2A and B shows the effect of the administration of arcaine
(0.1–10 mg/kg, i.p., 12 h post-training) on the memory of fear
assessed 2 or 7 days after training, respectively. Statistical analysis
(one-way ANOVA) revealed that arcaine, at the dose of 10 mg/kg,
decreased the freezing scores of animals tested at 2 days
[F3,16¼4,943, Po0.05, Fig. 2A] and 7 days after training
[F3,16¼3.461, Po0.05, Fig. 2B].
Fig. 3A and B shows the effect of arcaine (0.1 mg/kg) on
spermidine-induced improvement of the memory of fear, assessed
2 or 7 days after training, respectively. Statistical analysis (two-
way ANOVA) revealed a signiﬁcant pretreatment (saline or
arcaine) versus treatment (saline or spermidine) interaction at
2 days [F1,16¼22.29, Po0.05, Fig. 3A] and 7 days after training
[F1,16¼14.66, Po0.05, Fig. 3B], indicating that arcaine prevented
spermidine-induced increase of freezing scores.
Fig. 4A and B shows the effect of spermidine (1 mg/kg) on
arcaine-induced impairment of the memory of fear assessed 2 or
7 days after training, respectively. Statistical analysis (two-way
ANOVA) showed a signiﬁcant pretreatment (saline or spermidine)
versus treatment (saline or arcaine) at 2 days [F1,16¼25.26,
Po0.05, Fig. 4A] and 7 days after training [F1,16¼33.75, Po0.05,
Fig. 4B], revealing that spermidine prevented arcaine-induced
decrease of freezing scores.
4. Discussion
The current study showed that while the 12 h after training
administration of the polyamine spermidine improves (Fig. 1), the
injection of arcaine, an antagonist of the polyamine binding site at
the NMDA receptor, impairs (Fig. 2) the persistence of memory of
contextual fear conditioning, assessed 2 and 7 days after training.
We also showed that arcaine, doses that have no effect per se on
memory, prevented the facilitatory effect of spermidine on mem-
ory of fear assessed 2 and 7 days after training (Fig. 3). Accordingly,
spermidine prevented the detrimental effect of arcaine on mem-
ory persistence (Fig. 4) assessed 2 and 7 days after training.
Current evidence suggests that systemic administration of
spermidine immediately after training improves the context
memory of fear (Camera et al., 2007). Moreover, the early post-
training administration of arcaine impairs the memory of inhibi-
tory avoidance task (Rubin et al., 2001) and contextual fear
conditioning (Camera et al., 2007; Rubin et al., 2004). Since the
administration of spermidine 6 h post-training does not alter the
memory of inhibitory avoidance task (Berlese et al., 2005), it has
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Fig. 1. Effect of 12 h post-training intraperitoneal administration of spermidine on
the memory of fear, assessed 2 (A) or 7 (B) days after training. nPo0.05 compared
with vehicle by the SNK. Data are the meansþS.E.M. of percentage of freezing for
5 animals in each group.
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Fig. 2. Effect of 12 h post-training arcaine on the memory of fear, assessed 2 (A) or
7 (B) days after training. nPo0.05 compared with vehicle by the SNK. Data are the
meansþS.E.M. of percentage freezing for 5 animals in each group.
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been suggested that polyamines play a role only in the early stages
of memory consolidation. However, whether polyamines alter late
memory consolidation, related to persistence, it is still unknown.
This question is particularly relevant, considering that existing
evidence suggests that polyamines endogenously modulate mem-
ory, presumably by activating NMDA receptors (Rubin et al., 2001,
2004).
Transport of polyamines across the blood–brain does exist but
it is limited, with a brain uptake index of approximately 5% (Shin
et al., 1985; Diler et al., 2002). However, previous studies have
shown that only minute amounts of polyamines are necessary to
improve memory when injected into the amygdala and hippo-
campus (within the picomole range, Rubin et al., 2000, 2004).
Therefore, it is plausible that the systemic pharmacologic doses of
polyamines may cause biological relevant increases in the con-
centration of polyamines in the brain.
In this context, Shimizu et al. (2000) have shown that reactiva-
tion of NMDA receptors of the CA1 region in the following days
and week(s) after learning is crucial for the formation of the long
term contextual fear memory (Shimizu et al., 2000). These ﬁndings
have suggested that persistent NMDA receptor activation in the
ﬁrst several days after training is important to establish remote
memories, and are in agreement with the ﬁndings that LTM
persistence requires NMDA receptor activation in the ventral
tegmental area (VTA), late after training. Accordingly, the intra-
VTA infusion of the NMDA receptor antagonist AP5, 12 h after
training, impairs long term memory assessed on day 14, but not on
day 2 post-training. Moreover, the intra-VTA infusion of NMDA
12 h after training enhances long-term retention on day 14, but
not on day 2 after training (Rossato et al., 2009). In line with this
view, the administration of nicotinic and muscarinic antagonists
(Parﬁtt et al., 2012), and protein inhibitors (Bekinschtein et al.,
2007, 2008) 12 h after training impairs inhibitory avoidance
performance on day 7, but not on day 2 post-training. These
ﬁndings have led investigators to propose that, as a general rule,
late molecular events that take place in the rat hippocampus 12 h
after acquisition affect memory persistence at 7–14 days but not at
2 days after training, in the inhibitory avoidance task. Our experi-
ments, however, revealed that 12 h post-training injections of
polyamine ligands alter memory on both days 2 and 7 after
training. A possible explanation for these results could be that
spermidine and arcaine respectively improves and impairs the
formation of LTM (Berlese et al., 2005; Camera et al., 2007; Ceretta
et al., 2008; Gomes et al., 2010; Guerra et al., 2006, 2011, 2012;
Rosa et al., 2012; Rubin et al., 2000, 2001, 2004). Notwithstanding,
spermidine administration 6 h after training does not alter the
performance of rats at testing, performed 24 h after training, in the
inhibitory avoidance task (Berlese et al., 2005). Therefore, it seems
unlikely that a delayed injection, such as the performed in the
current study, improves the formation of LTM. As a consequence,
our results do not seem to ﬁt in the current behavioral models and
interpretations that injections performed 12 h after training do not
alter the performance of the animals when they are tested 48 h
after training. While one might conclude, based on the current
results, that polyamines may have a broader temporal effect than
anisomycin (Bekinschtein et al., 2007) on the stabilization of the
memory of fear, further studies have to be performed in order to
clarify the relative importance of the polyaminergic modulation of
fear memory and its full temporal window. This is particularly
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Fig. 3. Effect of 11:30 h post-training arcaine (0.1 mg/kg) and 12 h post-training
spermidine (10 mg/kg) on the memory of fear, assessed 2 (A) or 7 (B) days after
training. nPo0.05 compared with vehicle by the SNK. Data are the meansþS.E.M.
of percentage of freezing for 5 animals in each group.
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Fig. 4. Effect of 11:30 h post-training spermidine (1 mg/kg) and 12 h post-training
arcaine (10 mg/kg) on the memory of fear, assessed 2 (A) or 7 (B) days after
training. nPo0.05 compared with vehicle by the SNK. Data are the meansþS.E.M.
of percentage of freezing, for 5 animals in each group.
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relevant because in the current study spermidine and arcaine were
administered systemically, while in the study of Bekinstein and
colleagues anisomicyn was injected into the hippocampus. Such a
difference, that may cause an action of polyaminergic agents in
cerebral structures other than the hippocampus may have con-
tributed for this apparent disparity.
Transport of polyamines across the blood–brain does exist but
it is limited, with a brain uptake index of approximately 5% (Shin
et al., 1985; Diler et al., 2002). However, previous studies have
shown that only minute amounts of polyamines are necessary to
improve memory when injected into the amygdala and hippo-
campus (within the picomole range, Rubin et al., 2000, 2004).
Therefore, it is plausible that the systemic pharmacologic doses of
polyamines may cause biological relevant increases in the con-
centration of polyamines in the brain.
In summary, this study shows that spermidine and arcaine,
polyamine binding site ligands at the NMDA receptor, respectively
improves and impairs the persistence of memory of contextual
fear conditioning. These ﬁndings suggest that polyamines mod-
ulate memory persistence, opening up arrange of possibilities for
further studies on the functions of polyamines, including the
mechanisms by which spermidine facilitates memory persistence,
that seems to involve the NMDA receptor.
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